The Intelesens-Scanadu team is led by CTO Prof Jim McLaughlin (Applied Physicist) from Intelesens and CHIC-Ulster Ulster University. The overall Principal Engineers Ian McCullough (Systems Development) and Bob Gardner (Manufacturing) make up a 20 strong Trans-Atlantic engineering team.
Intelesens based in Belfast, Northern Ireland, specializes in intelligent wireless vital signs monitoring. The team has an integrated approach to this XPRIZE and has partnered with international clinical diagnostics leaders Randox, represented by Dr. Mary Jo Kurth (Biochemist). Clinical expertise has been provided by the renowned cardiology consultant Dr. David McEneaney and the team has a scientific underpinning provided by the Connected Health Innovation Centre of the Ulster University.
Scanadu Inc., a Silicon Valley based medtech company, previously led by Walter de Brouwer, CEO of Scanadu, has joined forces with Intelesens (formerly Zensor) to create team Intelesens-Scanadu.
Based at NASA Ames Research Park, Scanadu is a medtech company that designs a suite of products for consumers to better understand their health. Scanadu was founded in 2011 and is now led by Jaime Tenedorio
Our XPRIZE team consists of a collaboration between medical doctors, electrical engineers, chemists, mechanical engineers, mathematicians, designers and data scientists who are in pursuit of designing the ultimate tricorder device that has the potential to dramatically change today’s healthcare industry and put the power of medicine back into the hands of the people.
About Team Leader
Prof McLaughlin OBE, a physicist, is a Fellow of the Institute of Physics and the Irish Academy of Engineering and a Member of the IEEE. He has developed significant initiatives within research, technology-transfer, outreach and teaching since 1986, being awarded a Senior-Distinguished Research-Fellowship by Ulster. Presently, as a Professor in the School of Engineering he is also the Director of the Engineering Research Institute and Director of NIBEC. His salient disciplines address Connected-Health, nanotechnology and related bio-sensing/point of care diagnostic applications. He was awarded an OBE for his services to Research and Economic Development in Northern Ireland.
He has attained in excess of three-hundred publications (H index-34), supervised over 35 PhD’s and he has been honoured as an invited speaker at over thirty International Conferences and he has personally attracted over £42m of funding.
In recent years Professor McLaughlin’s over-arching strategy is to develop a strong Connected-Health Platform within the EU (as a Co-Director of the European-Connected-Health-Alliance). This work involves linking bioengineering and computing sciences with sensor technology developed within NIBEC and thus facilitating clinically-led research initiatives to benefit the healthcare sector. He has recently co-led a £5m Connected-Health Innovation Centre (CHIC) and followed this with a new £7m Biodevices-Laboratory.
A holder of over thirty patents, including one for the world’s best-selling disposable medical electrode, he has successfully co-founded a set of spin-out companies including the highly successful connected health company – Intelesens-Ltd. and more recently SiSaF-Ltd. He has acted as a consultant associated with key-processes and patents associated with Heartscape and Heartsine.
Sam De Brouwer
Virginia Faro Maza
Mary Jo Kurth
|Walter De Brouwer|